OncLive Staff

Articles

Gulhati Details Treatments and Advances in Pancreatic Cancer

May 2nd 2024

Prateek Gulhati, MD, PhD, delivers takeaways from his presentation at the 2022 Annual Oncology Clinical Practice and Research Summit and key trials in pancreatic cancer that have moved the field forward.

Husband and Wife Duo Pursue Medicine Together

May 2nd 2024

Manmeet Singh Ahluwalia, MD, and his wife, Harneet Kaur Walia, MD, say that they learn from each other’s experiences and share in successes.

Investigators Highlight Improvements in Immune and Endocrine Therapies for Breast Cancer

May 2nd 2024

Breast oncologists recap findings from the 2022 San Antonio Breast Cancer Symposium.

Dr Kyriakopoulos on the Investigation of Masofaniten Plus Enzalutamide in mCRPC

March 7th 2024

Dr Kyriakopoulos sheds light on the potential synergy between masofaniten and enzalutamide when used in combination for patients with prostate cancer.

Camidge and Farmen Discuss the Nuances of Cancer Care and Patient Advocacy

March 4th 2024

Camidge and Farmen talk through patient advocacy, Farmen’s cancer diagnosis, and the people who rallied around Farmen during the early days of her disease.

Kang Highlights Considerations for the Integration of Toripalimab into Nasopharyngeal Carcinoma Clinical Practice

February 29th 2024

Dr Kang discusses the significance of the FDA approval of toripalimab for nasopharyngeal carcinoma and his anticipated use of the agent.

Mims Expands on the Evaluation of Emavusertib in the TakeAim Leukemia Trial of AML and MDS

February 26th 2024

Dr Mims discusses the utility of emavusertib in acute myeloid leukemia and myelodysplastic syndrome and the rationale for the TakeAim Leukemia trial.

Tripathy Talks Through the Enduring Impact of the Miami Breast Cancer Conference

February 22nd 2024

Dr Tripathy discusses the unique aspects of the Miami Breast Cancer Conference that make it worth returning to year after year.

Kitko and Patel Emphasize the Importance of GVHD Research and Awareness

February 19th 2024

Drs Kitko and Patel discuss graft-versus-host disease recognition, treatment selection, and ongoing research with novel agents and biomarkers of response.

Camidge and Kelley Share the Details of Practicing Within Various Health Care Models

February 15th 2024

Drs Camidge and Kelley discuss the ways Dr Kelley’s passion for research guided his early career path.

FDA Approval Insights: Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced/Metastatic Urothelial Carcinoma

February 12th 2024

Dr Galsky discusses the FDA approval of enfortumab vedotin plus pembrolizumab for patients with locally advanced or metastatic urothelial cancer.

Community Oncologists on the Importance of Self-Reliance and Collegial Trust as Women in Medicine

February 8th 2024

Drs Jacob, Van Der Wall, and Wright-Browne discuss challenges and growth opportunities they have experienced throughout their careers.

Lunning and Brander Emphasize the Importance of Early CLL Diagnosis and Treatment

February 5th 2024

Drs Lunning and Brander discuss the evolution of chronic lymphocytic leukemia management.

Camidge and Okuyama Sasaki Highlight How Safety Net Hospitals Widen the Scope of Cancer Care

February 1st 2024

Drs Camidge and Okuyama Sasaki discuss the goals of safety net hospitals and the dynamics of helping low-income patients access cancer treatments.

Expert and Patient Perspectives on AE Management With FGFR Inhibitors in Cholangiocarcinoma

January 29th 2024

Goyal, Bishop, Kelley, and Kuhlman discuss ways to prepare patients with cholangiocarcinoma for FGFR inhibitor–related adverse effects.

FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL

January 25th 2024

Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma.

Lunning and Maddocks Talk Through Frontline MCL Management

January 22nd 2024

Drs Lunning and Maddocks discuss the management of MCL in the up-front setting.

Camidge and Leland Discuss the Road to a Multifaceted Biotechnology Career

January 18th 2024

Drs Camidge and Leland discuss various roles in the biotechnology field and the intricacies of starting a biotechnology company.

FDA Approval Insights: Nirogacestat in Progressing Desmoid Tumors Requiring Systemic Treatment

January 15th 2024

Dr Kasper discusses the FDA approval of nirogacestat for patients with progressing desmoid tumors; key efficacy, safety, and quality-of-life outcomes from the pivotal DeFi trial; and findings from an analysis investigating tumor volume and T2 hyperintensity changes with nirogacestat in patients enrolled in DeFi.

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

January 11th 2024

Drs Monk and Tarantino highlight current research investigating B7-H4–directed antibody-drug conjugates. in multiple solid tumor types.